Last $87.26 USD
Change Today -0.79 / -0.90%
Volume 251.2K
CHE On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for chemed corp (CHE)

Although debt as a percent of total capital increased at Chemed Corp. over the last fiscal year to 29.02%, it is still in-line with the Healthcare Providers and Services industry's norm. Additionally, even though there are not enough liquid assets to satisfy current obligations, Operating Profits are more than adequate to service the debt. Accounts Receivable are among the industry's worst with 23.90 days worth of sales outstanding. This implies that revenues are not being collected in an efficient manner. Last, Chemed Corp. is among the least efficient in its industry at managing inventories, with 2.49 days of its Cost of Goods Sold tied up in Inventories.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Dec 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
Assets    
Cash and Equivalents49.938.169.584.4
TOTAL CASH AND SHORT TERM INVESTMENTS49.938.169.584.4
Accounts Receivable113.077.993.391.8
TOTAL RECEIVABLES113.077.993.391.8
Inventory7.78.77.16.7
Prepaid Expenses10.311.411.417.8
Deferred Tax Assets, Current15.112.513.720.3
Other Current Assets0.82.12.63.7
TOTAL CURRENT ASSETS196.8150.8197.7224.7
Gross Property Plant and Equipment164.8184.9209.4224.4
Accumulated Depreciation-104.4-117.3-131.5-143.6
NET PROPERTY PLANT AND EQUIPMENT60.467.677.880.8
Goodwill458.3460.6465.8466.9
Deferred Tax Assets, Long Term0.20.2----
Other Intangibles76.873.771.368.8
Other Long-Term Assets37.643.247.052.7
TOTAL ASSETS830.2795.9859.6893.7
    
LIABILITIES & EQUITY    
Accounts Payable44.737.948.541.8
Accrued Expenses77.078.587.6113.5
Short-Term Borrowings11.110.3----
Current Portion of Long-Term Debt/Capital Lease------183.6
Current Income Taxes Payable1.20.14.90.1
Other Current Liabilities, Total15.318.615.825.0
TOTAL CURRENT LIABILITIES149.3145.4156.8364.0
Long-Term Debt159.2166.8174.9--
Deferred Tax Liability Non-Current25.129.527.727.3
Other Non-Current Liabilities34.540.647.053.5
TOTAL LIABILITIES368.1382.2406.3444.8
Common Stock30.430.931.632.2
Additional Paid in Capital365.0398.1437.4481.0
Retained Earnings473.3546.8623.0686.1
Treasury Stock-408.6-564.1-640.7-752.6
Comprehensive Income and Other2.02.02.02.2
TOTAL COMMON EQUITY462.0413.7453.3448.9
TOTAL EQUITY462.0413.7453.3448.9
TOTAL LIABILITIES AND EQUITY830.2795.9859.6893.7
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CHE:US $87.26 USD -0.79

CHE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amedisys Inc $13.78 USD +0.03
Hill-Rom Holdings Inc $36.66 USD -0.12
Integra LifeSciences Holdings Corp $45.30 USD -0.22
STERIS Corp $49.48 USD -0.07
West Pharmaceutical Services Inc $43.76 USD +0.73
View Industry Companies
 

Industry Analysis

CHE

Industry Average

Valuation CHE Industry Range
Price/Earnings 21.2x
Price/Sales 1.1x
Price/Book 3.4x
Price/Cash Flow 14.4x
TEV/Sales 0.9x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMED CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.